Semprus Biosciences ends $18m funding round
Semprus Biosciences Inc. closes an $18 million Series B funding round, which CEO David Lucchino says it will use to build out its management team and fund manufacturing ramp-up for its nanotech catheter coating. Semprus BioSciences reeled in $18 million in Series B financing for its nanotech medical device coating. Semprus CEO David Lucchino told […]